REQUEST A DEMO
Total
USD $0.00
Search more companies

Mediforma Pharma d.o.o. (Croatia)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers
Full name: Mediforma Pharma d.o.o. Profile Updated: October 06, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Mediforma Pharma d.o.o. is based in Croatia. The head office is in Zagreb. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. Mediforma Pharma d.o.o. was incorporated on December 10, 2025. The total number of employees is currently 8 (2024). From the latest financial highlights, Mediforma Pharma d.o.o. reported a net sales revenue increase of 25.62% in 2024. There was a total growth of 0.34% in Mediforma Pharma d.o.o.’s total assets over the same period. The net profit margin of Mediforma Pharma d.o.o. decreased by 0.15% in 2024.

Headquarters
Froudeova 7 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Mediforma Pharma d.o.o. report to view the information.

Website: http://www.mediformapharma.com

Basic Information
Total Employees:
Purchase the Mediforma Pharma d.o.o. report to view the information.
Financial Auditors:
Purchase the Mediforma Pharma d.o.o. report to view the information.
Incorporation Date:
December 10, 2025
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Mediforma Pharma d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
25.62%
Total operating revenue
25.62%
Operating profit (EBIT)
23.38%
EBITDA
30.53%
Net Profit (Loss) for the Period
13.07%
Total assets
0.34%
Total equity
64.88%
Operating Profit Margin (ROS)
-0.05%
Net Profit Margin
-0.15%
Return on Equity (ROE)
-30.5%
Debt to Equity Ratio
-154.25%
Quick Ratio
-0.14%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?